Clinical trial Recruiting at 1 site Observational Ages 18 and up

Blood lipid and ceramide profiles in atrial fibrillation

Official title: Association of Peripheral Blood Lipidomic and Ceramide Profiles With Atrial Fibrillation: A Prospective Multi-Cohort Observational Study

Run by First Affiliated Hospital Xi'an Jiaotong University · NCT07757282 · Data updated 2026-11-12

This study tests whether blood lipid and ceramide patterns differ between people with atrial fibrillation and those with other heart diseases.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedJune 15, 2017
Main results expectedJanuary 2027
Study endsFebruary 2027
Registry record updatedAugust 11, 2026
Trial IDNCT07757282 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with atrial fibrillation or with cardiovascular disease but no AF, who can provide informed consent and have suitable blood samples.

Probably not a fit

Participants with AF or cardiovascular disease who have unsuitable blood samples or do not show any lipidomic or ceramide differences related to AF may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multi-cohort observational study comparing peripheral blood lipidomic features and ceramide profiles in adults with atrial fibrillation to controls with cardiovascular disease but no AF. One cohort will undergo untargeted lipidomic profiling and another will have targeted ceramide assays. Participants are classified by Holter monitoring and clinical data, and samples are analyzed to explore associations with atrial fibrillation. The study is conducted at the First Affiliated Hospital of Xi’an Jiaotong University, without an interventional treatment. Findings could help clarify whether lipid and ceramide patterns are linked to AF pathophysiology.

Why it matters

Potential benefit: If successful, the results may improve understanding of AF biology and identify potential biomarkers for risk or diagnosis.

How similar studies have gone: Prior research suggests lipid and sphingolipid metabolism may be linked to AF, but translationally useful biomarkers remain to be validated; this study adds targeted comparisons.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older.
* Participants who are able to provide informed consent.
* Participants diagnosed with atrial fibrillation based on Holter monitoring, or control participants with other cardiovascular diseases and no documented atrial fibrillation.
* Participants with available peripheral blood samples for untargeted lipidomic profiling or targeted ceramide analysis.

Exclusion Criteria:

* Inability or unwillingness to provide informed consent.
* Missing key clinical information.
* Missing or poor-quality peripheral blood samples unsuitable for lipidomic or targeted ceramide analysis.
* Participants considered unsuitable for this study by the investigators.

Where it's running

  • First Affiliated Hospital of Xian JiaotongUniversity
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.